Showing results (961-970 of 9,403) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|March 4, 2006
Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humansJulie Grenier, Caroline Fradette, Gaetano Morelli, et al.Clinical Pharmacology and Therapeutics|March 4, 2006
Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic modelFloris H M Vanmolkot, Bart J E P Van der Schueren, Jan N J M de HoonClinical Pharmacology and Therapeutics|December 20, 2007
Declining public health burden of digoxin toxicity from 1991 to 2004K Haynes, Df Heitjan, Pa Kanetsky, et al.Clinical Pharmacology and Therapeutics|January 19, 2008
Clinical pharmacology in the molecular eraC T DolleryClinical Pharmacology and Therapeutics|January 24, 2008
The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancerY Kaida, N Inui, T Suda, et al.Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.Clinical Pharmacology and Therapeutics|November 1, 1996
The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquinB A Hamelin, J Turgeon, F Vallée, et al.Clinical Pharmacology and Therapeutics|November 1, 1996
Efficacy of buspirone in smoking cessation: a placebo-controlled trialN G Schneider, R E Olmstead, C Steinberg, et al.Clinical Pharmacology and Therapeutics|November 1, 1996
Regression of Henoch-Schönlein disease with intensive immunosuppressive treatmentR Faedda, M Pirisi, A Satta, et al.Clinical Pharmacology and Therapeutics|November 1, 1996
Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjectsW J ElliottPageof 941